Related Experiment Video
Updated: Nov 1, 2025
03:23
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
1.1K
Clozapine-Induced Eosinophilia: a Case Report.
Francesco Monteleone1, Márcia Gonçalves2, Luís Fonseca1
1Psychiatry and Mental Health Department of Hospital Senhora da Oliveira, Guimarães, Portugal.
Revista Colombiana De Psiquiatria (English Ed.)
|June 25, 2021
Summary
Clozapine is a vital treatment for resistant schizophrenia, but can cause eosinophilia. This case highlights the need for careful management of this side effect to avoid unnecessary drug withdrawal and symptom worsening.
Area of Science:
- Psychiatry
- Pharmacology
- Hematology
Background:
- Clozapine is a critical antipsychotic for treatment-resistant schizophrenia.
- Its use is often limited by concerns over adverse effects like eosinophilia.
Observation:
- A young male with treatment-resistant schizophrenia developed significant eosinophilia after initiating clozapine.
- The patient was asymptomatic, and other causes for eosinophilia were ruled out.
Findings:
- Diagnosis of clozapine-induced eosinophilia was made.
- Discontinuation of clozapine normalized eosinophil counts but led to symptom exacerbation.
Implications:
- This case underscores the challenges in managing clozapine-induced eosinophilia.
- Lack of clear guidelines may lead to premature clozapine withdrawal, negatively impacting schizophrenia treatment outcomes.
